The law offices of Marcotte and Ellison occupied the fourteenth floor of the Harbor Trust Building, a glass-and-steel tower that had been built during the boom years and had somehow survived the bust. The firm's reception area was decorated in muted grays and blues, with abstract paintings on the walls and a receptionist who looked like she had been hired for her ability to ignore distractions. Hale sat in a leather chair that was too soft for comfort, waiting for the meeting that would determine whether the securities fraud case had a future.
Isaac Voss sat beside him, his heavy hands folded on his knees. The longshoreman had dressed for the occasion in a jacket that was too tight across the shoulders and a tie that had probably belonged to his father. He looked uncomfortable in the corporate surroundings, but his eyes were steady. He had come this far. He was not going to back down now.
The conference room door opened, and a man in his sixties emerged. He was tall and thin, with silver hair combed straight back from a high forehead and the kind of patrician bearing that came from generations of privilege. His suit was perfectly tailored, and his handshake was firm and brief. This was Arthur Marcotte, the senior partner of Marcotte and Ellison, and according to Ida Cross, one of the best securities litigators in the Union States.
"Mr. Hale, Mr. Voss. Please come in."
The conference room was dominated by a long table of polished wood, surrounded by chairs that matched the one in the reception area. The windows looked out over the harbor, where the afternoon sun was breaking through the clouds and casting long shadows across the water. A woman was already seated at the table, younger than Marcotte by two decades, with short dark hair and the kind of focused attention that Hale recognized from his years as an investigator.
"My partner, Diana Ellison," Marcotte said. "She'll be handling the day-to-day litigation if we take the case."
Ellison stood and shook hands with both men. Her grip was stronger than Marcotte's, and her eyes were sharper. "I've read the Register stories. I've also read the documents you sent over. The adverse event data, the reclassification memo, the Orvis testimony. It's a compelling narrative."
"But?" Hale asked.
"But narrative is not enough for a securities fraud case. We need to prove that Ravenwood made false statements in their regulatory filings, that those statements were material to investors, and that our clients purchased shares that can be traced to those specific filings. The first two are achievable. The third is the challenge."
"The tracing requirement," Voss said.
"Exactly. Under the Union States Securities Act, a plaintiff in a Section 11 claim must prove that the shares they purchased were issued under the registration statement that contained the false statements. Shares are fungible. Once they enter the market, it's extremely difficult to trace a specific purchase to a specific document." Ellison opened a folder on the table. "I've reviewed your fund's trading records, Mr. Voss. The pension fund purchased Ravenwood stock in March of last year, after the quarterly filing that contained the false safety statements about Exaltrex. But Ravenwood had multiple stock issuances outstanding at that time. We need to prove that the shares you bought were part of the specific issuance covered by that quarterly filing."
"Is that possible?"
"It's possible, but it requires a forensic accounting analysis. We need to map the flow of shares from the corporate issuance records to the trading records of the fund's broker. It's painstaking work, and it's expensive." Ellison looked at Hale. "Ida Cross told me you've been working with a forensic accountant."
"We've identified one. A firm in Meridian City that specializes in securities tracing. They've agreed to take the case on a reduced fee basis, given the circumstances."
"That helps. But even with the tracing analysis, we're going to face a motion to dismiss. Ravenwood's lawyers will argue that the tracing requirement can't be met, that the market for their stock was too complex, that the plaintiffs can't prove their shares correspond to the allegedly fraudulent registration statement." Ellison closed the folder. "We've seen this argument succeed in other cases. It's a formidable hurdle."
"Then why are we here?" Voss asked.
Marcotte answered, his voice calm and measured. "Because the facts of this case are extraordinary. The bad faith finding from Judge Goode is a significant piece of evidence. The criminal investigation by the Union States Attorney gives the case credibility. And the testimony of Dr. Orvis and the other witnesses establishes that the fraud was not just a matter of omitted information—it was a deliberate scheme to conceal lethal risks." He paused. "The tracing requirement is a hurdle, but it's not insurmountable. If the forensic analysis can trace the shares, and if we can frame the fraud in terms that a judge will find compelling, we have a chance."
"A chance isn't enough," Hale said. "We need to win."
"You never know whether you'll win until the verdict is read. That's the nature of litigation." Marcotte leaned forward, his pale eyes fixed on Hale. "But I've been doing this for thirty-five years, and I can tell you that this case is stronger than most. The evidence is substantial. The witnesses are credible. The public interest is on our side. Those things matter, even in securities litigation."
"What about the cost?" Voss asked. "The union can contribute some money, but we're not a wealthy fund."
"We'll take the case on contingency. If we win, our fees come from the judgment. If we lose, you owe us nothing." Marcotte glanced at Ellison. "We don't take every case that comes through the door. We take cases we believe in. This is one of them."
Voss looked at Hale, then back at Marcotte. "Then let's do it."
The meeting continued for another two hours. Ellison walked through the elements of the complaint they would file: a detailed description of the Exaltrex compassionate use program, the internal memos showing knowledge of the lethal risks, the reclassification of adverse events, the false statements in the quarterly filing. She explained the legal theory of tracing and the forensic analysis they would need to support it. She outlined the discovery process and the likely timeline for the case.
By the time they finished, the afternoon sun had moved across the harbor, and the conference room was filled with long shadows. Hale stood up, his back stiff from the hours of sitting.
"There's one more thing," Ellison said as they were leaving. "The criminal investigation. Elaine Morse is a good prosecutor, but she's careful. She won't indict unless she's confident she can win. If the grand jury returns indictments, it will strengthen our civil case significantly. If they don't, Ravenwood's lawyers will use that to argue that there was no fraud."
"When will we know about the grand jury?"
"Morse is presenting evidence next week. The witnesses are scheduled to testify. We should know within the month."
Hale nodded and walked out of the conference room with Voss. The elevator carried them down to the lobby, and they emerged onto the street where the late afternoon light was fading into the gray of evening.
"You think we can win this?" Voss asked.
"I think we have to." Hale shook the longshoreman's hand. "Thank you for doing this. I know it's not easy."
"It's not easy. But my father deserved better. All of them did." Voss buttoned his jacket against the wind. "I'll be in touch."
He walked away toward the bus stop, his broad shoulders hunched against the cold. Hale watched him go, then turned and walked in the opposite direction, toward the offices of the Port Gantry Register.
Trina was at her desk when he arrived, the newsroom buzzing with the energy of the afternoon deadline. She looked up from her typewriter and gestured for him to sit.
"The securities case is moving forward," he said. "Marcotte and Ellison are taking it on contingency."
"That's good. What about the tracing requirement?"
"They think they can meet it. Forensic accounting analysis. It'll take time, but they're confident."
Trina leaned back in her chair. "I've been working on something. A follow-up to the original story. I've been tracking the other eleven facilities in the Exaltrex program, the ones besides Silver Pines. I've been calling families, pulling death certificates, trying to build a complete picture of what happened."
"What did you find?"
"More than I expected." She pulled a folder from the stack on her desk. "There are at least forty deaths across the twelve facilities that match the pattern. All within six to eight weeks of starting Exaltrex. All on the forty-milligram dose. All classified as natural causes. The oldest victim was ninety-two. The youngest was sixty-eight. They were mothers and fathers and grandparents. They had families who were told they died of old age." She handed the folder to Hale. "I'm running the story tomorrow. The full list of names, as many as I've been able to confirm."
Hale opened the folder and looked at the list. Forty names, arranged by facility and date of death. Some of them he recognized from his own research. Most of them he had never seen before. Each one was a person who had been told they were helping others, who had signed papers they could not read, who had died with their pupils constricted and their hearts racing, their deaths classified as something other than what they were.
"This is going to be hard for the families to read," he said.
"It's going to be hard. But they deserve to know the truth. They deserve to know that their loved ones didn't just die of old age. They were killed by a system that valued profit over their lives." Trina took the folder back. "I've spoken to some of the families already. They're angry. They want justice. Some of them want to sue."
"Tell them to call Marcotte and Ellison. The more plaintiffs we have, the stronger the case."
"I will." She paused, her eyes studying his face. "You look exhausted."
"I am exhausted. But I can't stop. Not yet."
"Have you heard from Marlene Draper?"
"No. She's gone. I don't know where."
Trina nodded slowly. "I've been thinking about her. About the way she played you. The trap with the flash drive, the arrest, the whole performance. She was very good at what she did."
"She was the best I've ever seen."
"But she also gave you the complete adverse event database. She gave you the reclassification memo. She gave you Orvis's address. Without those things, we wouldn't have the case we have now." Trina lit a cigarette. "Why would she set you up and then give you the evidence to tear the setup apart?"
Hale had been asking himself the same question for days. "I think she was trying to do both things at once. Control the damage to Ravenwood while also positioning herself as a cooperator. She wanted to be on the winning side, whichever side that turned out to be. If Ravenwood survived, she could say she tried to stop the leak. If the case brought the company down, she could say she helped the investigation."
"Do you think she'll testify at the grand jury?"
"She's already given her affidavit. Morse has it. Whether she appears in person depends on whether she thinks it's safe."
"She's still afraid."
"She should be. The machine is still running, and she was part of it." Hale stood up. "I need to talk to Ida. She's been working on the corporate structure evidence, the Draven Holdings connection. If we can prove Marcus Draven was personally profiting from the program, it changes the nature of the case."
"Call me if you need anything."
Hale walked out of the newsroom and down the creaking stairs to the street. The evening was cold, and the streetlights were flickering on along the waterfront. He walked to a pay phone on the corner and called Ida's office.
"I have something," Ida said when she answered. "The subpoena for the financial records came back. Draven Holdings received payments from Ravenwood totaling two-point-three million dollars over three years. The payments were routed through Kernow Clinical Services and Aspen Medical Partners, just like we thought. But there's more. The payments coincided with the enrollment numbers at the twelve facilities. Every time a new patient was recruited into the Exaltrex program, Draven Holdings received a payment."
"So he was paid per patient."
"Per patient. The more patients enrolled, the more money he made. The forty-milligram dose was part of it, too. The payment per patient increased if the patient was on the higher dose. Marcus Draven had a direct financial incentive to push the lethal dosage."
Hale felt the cold anger flare. "That's not just fraud. That's murder for profit."
"That's what I'm going to tell Elaine Morse. The financial records are being transmitted to her office tonight. The grand jury will have them by the end of the week."
"Good. That's good."
"There's one more thing. The securities complaint is ready to file. Marcotte and Ellison finished the draft this afternoon. They're filing it in federal district court tomorrow morning." Ida paused. "Once it's filed, it's public. The complaint names Marcus Draven, the six other committee members, and Ravenwood Pharmaceuticals as defendants. It's going to be on the front page of every financial newspaper in the country."
"Then the machine is about to take another hit."
"It is. But remember what Elaine Morse said. The machine fights back."
Hale hung up and stood in the phone booth, watching the traffic move past on Harbor Street. The machine had been fighting back since the beginning. It had tried to discredit him, arrest him, threaten him into silence. It had sent Marlene Draper to manipulate him and Latham Pryor's replacement to intimidate him. It had fought every step of the way.
But the machine was losing. The grand jury was convening. The securities complaint was being filed. The Register was publishing the names of forty dead patients. The truth was spreading, and the machine could not spin it away.
He walked back to the boarding house through the cold evening, his hands in his pockets and his mind already moving ahead to the next step. The grand jury testimony. The securities filing. The FDOA hearing. There was still so much to do, so many pieces to move into place.
But for the first time since the night Edith Morrow died, Hale felt like he could see the end. Not the end of the fight—the fight would go on for months, maybe years. But the end of the machine. The moment when the last layer was peeled back, and the truth was exposed, and the people who had built this system of death would have to face what they had done.
He reached the boarding house and climbed the stairs to his room. The window looked out over the shipyards, where the cranes were still swinging against the darkening sky. He sat down at his small table and pulled out his notebook.
Securities complaint filed tomorrow. Grand jury convenes next week. Forty names in the Register. Draven Holdings payments tied to patient enrollment. Morse has the financial records. Marcotte and Ellison have the tracing analysis. The machine is breaking.
He closed the notebook and lay down on the narrow bed. Outside, the wind was picking up, and the first drops of rain were beginning to tap against the window. Somewhere in the city, the families of the dead were learning the truth about what had happened to their loved ones. Somewhere, Marcus Draven was reading the same news and calculating his next move. And somewhere, Marlene Draper was watching from the shadows, waiting to see which side would win.
Hale closed his eyes and let the exhaustion take him. Tomorrow, the fight would continue. But tonight, he could rest.
No comments yet. Be the first to comment!